From Molecule to Market, Faster.
AI Co-Scientist forDrug Discovery
Starting with mRNA therapeutics. Specialized AI agents that design, predict, and explain — powered by a provenance-grounded world model.
Start Anywhere. Go Faster.
AI assistance at the stages that matter most to your pipeline.
Target Discovery
Lead Optimization
Preclinical
Clinical Trials
Target Discovery
Lead Optimization
Preclinical
Clinical Trials
Purpose-Built for Biologics
Specialized pipelines for each therapeutic modality with validated experimental workflows
mRNA
Therapeutics
Optimize expression, stability, and immunogenicity with delivery-aware design.
- Codon optimization & UTR design
- Personalized neoantigen vaccines
- Protein replacement therapy
Protein
Binders & Scaffolds
Structure-informed design for binding specificity across diverse scaffold families.
- De novo protein design
- Bispecific & multispecific
- Tissue-targeting scaffolds
Peptide
Therapeutics
Rapid iteration on potency and stability with well-characterized validation assays.
- GLP-1R, GCGR agonists
- Cytokine mimetics
- Stapled & cyclic peptides
Why DeepBio Scientific
World Model Architecture
A provenance-grounded world model that reasons across biological systems, not just pattern-matching on molecules.
Higher Success Rates
Calibrated probability models predict and improve clinical success, addressing the 90% failure rate problem.
30-50% Time Savings
Cut years off development timelines with AI-driven automation across every pipeline stage.
AgentFabric™
Specialist agents debate and iterate, with a judge agent forcing explicit tradeoffs and decisions.
Trial Optimization
AI-generated protocols, patient matching, and eligibility criteria that maximize recruitment and success.
Full Audit Trail
Every prediction traced to source data. No hallucinations, just grounded, explainable reasoning.
Design & Platform Services
Flexible services tailored to your stage and strategy
Molecular Design
AI-driven molecule design, optimization, and validation per program
Preclinical
ADMET prediction, toxicity screening, and lead optimization per asset
Trial Optimization
Protocol design, patient stratification, and endpoint prediction per trial
Regulatory Intel
Submission guidance, compliance analysis, and documentation per filing
Enterprise Platform
Unlimited queries, full API access, dedicated support team, and custom integrations
Success Milestones
Performance bonuses on IND filing, phase advancement, and regulatory approval
Customer LTV
Single entry point expands over 4-year asset lifecycle
Partnership Model: Upfront per program, plus downstream royalty on successful commercialization
Join Us in Building a Disease-Free World
Partner with us to accelerate your therapeutic program from concept to clinic.